TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30257695

Group type: EXPERIMENTAL
Intervention: Program Sustainability Action Planning Training and technical assistance
Number of subjects: 24

Group type: COMPARATOR
Intervention: Comparison group (no specific intervention mentioned)
Number of subjects: 24
Study: 27029775

Group type: EXPERIMENTAL
Intervention: Web-based cessation programme with optimised text messaging intervention
Number of subjects: 860

Group type: COMPARATOR
Intervention: Web-based cessation programme alone
Number of subjects: 860

Group type: EXPERIMENTAL
Intervention: Text messaging intervention
Number of subjects: 860
Study: 24533890

Group type: EXPERIMENTAL
Intervention: Glycopyrronium
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hyoscine
Number of subjects: 90
Study: 21461716

Group type: EXPERIMENTAL
Intervention: Balneotherapy (21 patients) - 2 thermomineral water baths daily for 2 weeks
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Balneotherapy (21 patients)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (24 patients) - continued medical treatment and routine daily life
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (24 patients)
Number of subjects: 50
Study: 20345032

Group type: EXPERIMENTAL
Intervention: Impacted high tibial osteotomy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional high tibial osteotomy
Number of subjects: 30
Study: 16626957

Group type: EXPERIMENTAL
Intervention: Soy with trace isoflavones (<4 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Total milk protein
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Soy with 107 mg of total aglycone units of isoflavones
Number of subjects: 16
Study: 16710105

Group type: EXPERIMENTAL
Intervention: 99mTc-depreotide SPECT (DEP-SPECT)
Number of subjects: 29

Group type: COMPARATOR
Intervention: 18F-FDG PET (PET-FDG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Comparison of both methods
Number of subjects: 29
Study: 17516694

Group type: EXPERIMENTAL
Intervention: Oxybutynin XL 10 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tolterodine IR 4 mg/day
Number of subjects: 0
Study: 11068350

Group type: EXPERIMENTAL
Intervention: Homeopathy
Number of subjects: 165

Group type: COMPARATOR
Intervention: Orthodox medicine
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Complementary medicine users
Number of subjects: 165

Group type: COMPARATOR
Intervention: Non-complementary medicine users
Number of subjects: 165
Study: 8943602

Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia with propofol and sufentanil (group A)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Inhalational anaesthesia with isoflurane and nitrous oxide (group B)
Number of subjects: 16
Study: 1624154

Group type: EXPERIMENTAL
Intervention: Acetorphan
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206
Study: 6384848

Group type: EXPERIMENTAL
Intervention: butoconazole nitrate cream 2%
Number of subjects: 274

Group type: COMPARATOR
Intervention: clotrimazole vaginal tablets 200 mg/day
Number of subjects: 274
Study: 30668567

Group type: EXPERIMENTAL
Intervention: Head- or full body-ventilated PPE suits equipped with powered-air-purifying-respirators
Number of subjects: 19
Study: 28251157

Group type: EXPERIMENTAL
Intervention: ArmAssist robotic training
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (matched conventional arm training)
Number of subjects: 26
Study: 25475929

Group type: EXPERIMENTAL
Intervention: Teneligliptin 20mg plus metformin
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo plus metformin
Number of subjects: 204
Study: 22967035

Group type: EXPERIMENTAL
Intervention: Safinamide 100 mg/day
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study: 21576096

Group type: EXPERIMENTAL
Intervention: Proseal™ LMA (PLMA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: LMA Supreme™ (SLMA)
Number of subjects: 120
Study: 19782008

Group type: COMPARATOR
Intervention: HOMA-beta cell index in control subjects
Number of subjects: 32

Group type: COMPARATOR
Intervention: Stumvoll's early insulin secretion index in CF-NGT patients
Number of subjects: 32

Group type: COMPARATOR
Intervention: Insulin secretion rate (ISR) in CF-NGT and CFRD groups
Number of subjects: 32

Group type: COMPARATOR
Intervention: HOMA-beta cell index in CF-NGT patients
Number of subjects: 32
Study: 17135618

Group type: EXPERIMENTAL
Intervention: SBT
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: SBT+LOV
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: SBT+LOV (100% adherent)
Number of subjects: 182

Group type: COMPARATOR
Intervention: SBT+LOV (<100% adherent)
Number of subjects: 182
Study: 12706934

Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg/day for four weeks)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day for four weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 45
Study: 10921161

Group type: EXPERIMENTAL
Intervention: Yi Zhi Capsules (YZC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (Piracetam)
Number of subjects: 0
Study: 8769292

Group type: EXPERIMENTAL
Intervention: PEG solution 250 ml twice a day
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 1422792

Group type: EXPERIMENTAL
Intervention: Patients with cerebellar disease
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 16
Study: 6141335

Group type: EXPERIMENTAL
Intervention: gamma-vinyl GABA (3 g daily)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: gamma-vinyl GABA
Number of subjects: 24
Study: 30630109

Group type: EXPERIMENTAL
Intervention: Communities for Healthy Living (CHL) obesity prevention program
Number of subjects: 0
Study: 29477688

Group type: EXPERIMENTAL
Intervention: Tube shunt (350‐mm2 Baerveldt glaucoma implant)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC; 0.4 mg/ml for 2 minutes)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Tube shunt
Number of subjects: 242

Group type: COMPARATOR
Intervention: Trabeculectomy with MMC
Number of subjects: 242
Study: 27456094

Group type: EXPERIMENTAL
Intervention: Sources of Strength program
Number of subjects: 16

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 16
Study: 24491572

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg alone and gemfibrozil 600 mg BID for 5 days with a single dose of empagliflozin 25 mg on the third day.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg coadministered with rifampicin 600 mg.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg coadministered with probenecid 500 mg BID for 4 days.
Number of subjects: 36
Study: 22956656

Group type: EXPERIMENTAL
Intervention: 1 mg intradermal (i.d.) vaccination
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 4 mg intramuscular (i.m.) vaccination
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: 1 mg intramuscular (i.m.) vaccination
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 20119464

Group type: EXPERIMENTAL
Intervention: tapentadol IR (50, 75, or 100 mg every 4 or 6 hours, maximum TDD 500 mg)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: tapentadol ER (100, 150, 200, or 250 mg bid)
Number of subjects: 88

Group type: COMPARATOR
Intervention: tapentadol IR and tapentadol ER
Number of subjects: 88
Study: 17035945

Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate
Number of subjects: 360

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 360
Study: 16277587

Group type: EXPERIMENTAL
Intervention: Periodontal treatment before 28 weeks of gestation (N = 580)
Number of subjects: 870

Group type: COMPARATOR
Intervention: Control group receiving periodontal treatment after delivery (N = 290)
Number of subjects: 870

Group type: COMPARATOR
Intervention: Periodontal treatment (treatment group) vs. no treatment (control group)
Number of subjects: 870

Group type: COMPARATOR
Intervention: Periodontal treatment (treatment group) vs. gingivitis risk
Number of subjects: 870
Study: 11704445

Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 60

Group type: COMPARATOR
Intervention: HES 200/0.5
Number of subjects: 60
Study: 9627365

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate (MPA) 10 mg daily added to ERT
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT) in nonsmoking women
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy (ERT) in cigarette smokers
Number of subjects: 25
Study: 8063985

Group type: EXPERIMENTAL
Intervention: GDVM plus ADVANCE
Number of subjects: 78

Group type: COMPARATOR
Intervention: GDVM alone
Number of subjects: 78
Study: 3287837

Group type: EXPERIMENTAL
Intervention: Clofibric acid and nicotinic acid (Treatment group)
Number of subjects: 555
Study: 31166679

Group type: EXPERIMENTAL
Intervention: Ribociclib plus endocrine therapy (goserelin and either a nonsteroidal aromatase inhibitor or tamoxifen)
Number of subjects: 672

Group type: COMPARATOR
Intervention: Placebo plus endocrine therapy (goserelin and either a nonsteroidal aromatase inhibitor or tamoxifen)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Ribociclib plus endocrine therapy (in subgroup of 495 patients who received an aromatase inhibitor)
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Ribociclib plus endocrine therapy
Number of subjects: 672
Study: 28390934

Group type: EXPERIMENTAL
Intervention: Quadrivalent inactivated influenza vaccine (IIV4)
Number of subjects: 2278

Group type: COMPARATOR
Intervention: Comparator quadrivalent inactivated influenza vaccine (IIV4)
Number of subjects: 2278
Study: 25168032

Group type: EXPERIMENTAL
Intervention: Income conditions of $280, $127, $70, or $32 per week with prices of $0.12, $0.25, $0.50, and $1.00 per cigarette
Number of subjects: 15
Study: 23283585

Group type: EXPERIMENTAL
Intervention: Single dose of 0.5 Gy
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Single dose of 1.0 Gy
Number of subjects: 112
Study: 21245887

Group type: EXPERIMENTAL
Intervention: Lactobacillus sporogenes (350,000,000 c.f.u. added to breast milk or formula, once a day)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Control (no L. sporogenes supplementation)
Number of subjects: 221
Study: 18279295

Group type: EXPERIMENTAL
Intervention: Preventive measures adhering to the Belgian Guideline for Prevention of Pressure Ulcers
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Preventive measures not adhering to the Belgian Guideline for Prevention of Pressure Ulcers
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: No preventive measures
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Patients with at least one pressure ulcer
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Informal carers informed and motivated by home care nurse
Number of subjects: 744

Group type: EXPERIMENTAL
Intervention: Actual participation in prevention by patients and informal carers
Number of subjects: 744
Study: 16476114

Group type: EXPERIMENTAL
Intervention: Syzygium cumini tea
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Glyburide tablets
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo tea
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 27
Study: 12897500

Group type: EXPERIMENTAL
Intervention: Chronic whiplash injury patients
Number of subjects: 25

Group type: COMPARATOR
Intervention: Healthy age-matched control subjects
Number of subjects: 25
Study: 11138759

Group type: EXPERIMENTAL
Intervention: Korean participants
Number of subjects: 0

Group type: COMPARATOR
Intervention: American participants
Number of subjects: 0
Study: 9058613

Group type: EXPERIMENTAL
Intervention: Intravenous foscarnet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous ganciclovir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous cidofovir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local therapies (intraocular injections of ganciclovir and foscarnet)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release ganciclovir implant
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of local and systemic therapies
Number of subjects: 0
Study: 8132367

Group type: EXPERIMENTAL
Intervention: Fluconazole (400 mg on the first day, then 300 mg daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amphotericin B (0.5 mg/kg body weight) + Flucytosine (3 x 2.5 g daily)
Number of subjects: 40
Study: 3590088

Group type: EXPERIMENTAL
Intervention: Org 10172 500 U bd
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Org 10172 750 U bd
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Org 10172 1000 U bd
Number of subjects: 45
Study: 31432716

Group type: EXPERIMENTAL
Intervention: Single-use digital flexible ureteroscope (ZebraScope)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Reusable digital flexible ureteroscope (URF-V)
Number of subjects: 126
Study: 30585985

Group type: EXPERIMENTAL
Intervention: Dynamic mechanical allodynia (DMA) at the control site
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Vibratory hypesthesia at the control site
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Mechanical gain/loss with normal thermal detection at the affected site
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Mechanical gain/loss with normal thermal detection at the control site
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Pain Disability Index
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: SES affective pain perception scores
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: SF-36 subscores
Number of subjects: 74
Study: 27775461

Group type: EXPERIMENTAL
Intervention: MTX, intra-articular betamethasone and CyA
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo CyA
Number of subjects: 160
Study: 25891697

Group type: EXPERIMENTAL
Intervention: Tacrolimus modified release (TAC-MR) once daily
Number of subjects: 99

Group type: COMPARATOR
Intervention: Tacrolimus (TAC) twice daily
Number of subjects: 99
Study: 25197696

Group type: EXPERIMENTAL
Intervention: Gain/Loss Sharing and Buyback (GLB) contract combined with Sales Rebate and Penalty (SRP) contract
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gain/Loss contracts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loss aversion analysis
Number of subjects: 0
Study: 20964740

Group type: EXPERIMENTAL
Intervention: Healthy Nordic diet (ND)
Number of subjects: 88
Study: 19126556

Group type: EXPERIMENTAL
Intervention: Stentless Prima Plus bioprosthesis
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stented Perimount bioprosthesis
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 17505051

Group type: EXPERIMENTAL
Intervention: Pramlintide (180 microg)
Number of subjects: 88
Study: 15502479

Group type: EXPERIMENTAL
Intervention: 2% diquafosol
Number of subjects: 527

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 527
Study: 11983754

Group type: EXPERIMENTAL
Intervention: Mastectomy plus adjuvant oophorectomy and tamoxifen during luteal phase (n = 158)
Number of subjects: 565

Group type: COMPARATOR
Intervention: Mastectomy only (n = 289)
Number of subjects: 565
Study: 9817160

Group type: EXPERIMENTAL
Intervention: Nebulized L-NAME (10(-1) M)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7714088

Group type: EXPERIMENTAL
Intervention: Fed group (n = 7)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fasted group (n = 10)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both groups (fed and fasted)
Number of subjects: 12
Study: 2785610

Group type: EXPERIMENTAL
Intervention: School-based educational program with parental involvement and mass media coverage
Number of subjects: 22500

Group type: COMPARATOR
Intervention: Delayed intervention control condition
Number of subjects: 22500
Study: 825745

Group type: EXPERIMENTAL
Intervention: Trental 400 (1 tablet 3 times a day for 7 to 8 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 6446269

Group type: EXPERIMENTAL
Intervention: Autogenous saphenous vein
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Expanded polytetrafluoroethylene (PTFE)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Composite Dacron-autogenous vein (DV) grafts
Number of subjects: 87
Study: 30679671

Group type: EXPERIMENTAL
Intervention: Active formula (NUTURIS, large phospholipid coating of lipid droplets, mode diameter 3‐5 μm)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control formula (commercially available formula with smaller lipid droplets)
Number of subjects: 29
Study: 27798454

Group type: EXPERIMENTAL
Intervention: Laryngeal tube suction II (LTS II)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Endotracheal tube
Number of subjects: 50
Study: 24831862

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 74
Study: 24237617

Group type: EXPERIMENTAL
Intervention: myCompass program
Number of subjects: 720

Group type: COMPARATOR
Intervention: Attention control intervention
Number of subjects: 720

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 720
Study: 21464755

Group type: EXPERIMENTAL
Intervention: Milk-free infant rice cereal
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pureed carrots
Number of subjects: 39
Study: 19526329

Group type: EXPERIMENTAL
Intervention: Ergonomics counseling
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ergonomics counseling + Myofeedback training
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (Ergonomics counseling only)
Number of subjects: 36
Study: 17198065

Group type: EXPERIMENTAL
Intervention: Conveen anal plug (Coloplast Limited) used for 12 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no anal plug)
Number of subjects: 48
Study: 15132131

Group type: COMPARATOR
Intervention: 4 x 100‐mg capsules (reference)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 4 x 100‐mg tablets (test)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 1 x 400‐mg tablet (test)
Number of subjects: 33

Group type: COMPARATOR
Intervention: 4 x 100‐mg tablets versus 4 x 100‐mg capsules
Number of subjects: 33

Group type: COMPARATOR
Intervention: 1 x 400‐mg tablet versus 4 x 100‐mg capsules
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 33
Study: 12034517

Group type: EXPERIMENTAL
Intervention: Oral estradiol sequentially combined with dydrogesterone (oE2/D10)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Transdermal estradiol plus norethisterone acetate (tdE/NETA)
Number of subjects: 119
Study: 10464826

Group type: EXPERIMENTAL
Intervention: Spacehaler (250 micrograms beclomethasone dipropionate)
Number of subjects: 12

Group type: COMPARATOR
Intervention: MDI (250 micrograms beclomethasone dipropionate)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Spacehaler
Number of subjects: 12

Group type: COMPARATOR
Intervention: MDI
Number of subjects: 12
Study: 7853047

Group type: EXPERIMENTAL
Intervention: Streptokinase treatment for acute myocardial infarction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prevention of death from bleeding peptic ulcers
Number of subjects: 0
Study: 2404436

Group type: EXPERIMENTAL
Intervention: Tetracaine, adrenaline, and cocaine (TAC)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Cocaine alone
Number of subjects: 139
Study: 402508

Group type: EXPERIMENTAL
Intervention: 6 day regimen of cephalothin prophylaxis
Number of subjects: 200

Group type: COMPARATOR
Intervention: 2 day regimen of cephalothin prophylaxis
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: No detectable cephalothin in sera
Number of subjects: 200

Group type: COMPARATOR
Intervention: Detectable cephalothin in sera
Number of subjects: 200
Study: 31586420

Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg no load
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 30860570

Group type: EXPERIMENTAL
Intervention: Capivasertib (400 mg b.i.d. 4 days on/3 days off) with paclitaxel (90 mg/m2 on days 1, 8, and 15 of a 28-day cycle)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo with paclitaxel (90 mg/m2 on days 1, 8, and 15 of a 28-day cycle)
Number of subjects: 148
Study: 28814770

Group type: EXPERIMENTAL
Intervention: Post-stress physiology of sister cells after a semi-lethal heat challenge
Number of subjects: 0
Study: 26336043

Group type: EXPERIMENTAL
Intervention: Adaptive Compression Therapy (ACT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: 4-Layer Bandage (4LB)
Number of subjects: 12
Study: 23252914

Group type: EXPERIMENTAL
Intervention: Discharge-planning intervention combining chronic drug review, education, and enhanced transition-of-care communication
Number of subjects: 665

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: Discharge-planning intervention
Number of subjects: 665
Study: 21602474

Group type: EXPERIMENTAL
Intervention: 15% MVC
Number of subjects: 11

Group type: COMPARATOR
Intervention: 5% MVC
Number of subjects: 11
Study: 19635148

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal renal artery stenting (PTRAS) plus best medical treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PTRAS
Number of subjects: 0
Study: 16636345

Group type: EXPERIMENTAL
Intervention: Hyperthermia at 434 MHz
Number of subjects: 37

Group type: COMPARATOR
Intervention: Continuous ultrasound at 1 MHz at an intensity of 2.0 w/cm(2) 3 times a week
Number of subjects: 37

Group type: COMPARATOR
Intervention: Exercises (pendular swinging and stretching exercises 5 minutes twice a day every day)
Number of subjects: 37
Study: 14752407

Group type: EXPERIMENTAL
Intervention: alpha‐stat strategy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: pH‐stat
Number of subjects: 40
Study: 12468560

Group type: EXPERIMENTAL
Intervention: Vitamin C 500 mg daily
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Vitamin C 50 mg daily
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Dropout group
Number of subjects: 439